Nixamide vape research has been brought up recently among vapers who are weaning off of nicotine. On social media and in early lab discussions, nixamide is being called a “nicotine alternative,” offering the same ritual without the chemical dependency. But where did this compound come from, and does it actually work the way it’s promoted? Researchers are starting to test nixamide, exploring the effects on the body, and questioning whether marketing claims are actually factual.

For vapers looking to make informed, mindful choices about what goes into their devices, understanding the science behind nixamide is a crucial part of that journey.

The Birth of the Idea: From Vitamin to Vapor

Nixamide is rooted in nicotinamide (a form of vitamin B3). In food and supplements, nicotinamide has a long safety history. When companies began marketing it as part of vape liquids, they described it as delivering “pleasure, satisfaction, and enjoyment” through a compound structurally different from nicotine. A 2024 review titled Marketing of nicotinamide as nicotine replacement discusses how nixamide is positioned as a kind of nicotine-free substitute—but also flags how little human inhalation data exist (pmc.ncbi.nlm.nih.gov).

The idea took hold because it promised the same calming ritual without dependence—a way to quit without giving up the experience. But as more scientists examine the chemistry, the distinction between perception and proof is becoming clearer.

What Is Nixamide, Really?

Before diving deeper into current nixamide vape research, it helps to understand what this compound actually is—and what it isn’t. Nixamide is often marketed as a “nicotine alternative,” but its origins are less mysterious than they sound. It’s derived from nicotinamide, a form of vitamin B3 that’s already well-known in nutrition and skincare science. The difference is how it’s being repurposed. When inhaled, nicotinamide’s behavior in the body may not mirror nicotine’s, which is where much of the current research and debate begins.

For readers looking to explore this background in more depth, What Is Nixamide: A Straight-Talk Guide to a New Nicotine Alternative breaks down how nixamide came to market, the chemistry behind it, and why it’s generating attention among vapers searching for non-nicotine options.

Understanding its foundation makes it easier to see why so many studies are focused not only on its chemical safety but also on whether it can truly deliver nicotine-like satisfaction without addiction.

What the Lab Tests Reveal (and Hide)

Mismatch Between Labels and Contents

A 2024 JAMA study tested e-liquid and disposable products marketed with nicotinamide, nixotine, nixodine, and nixamide labels. They found “substantial discrepancies” in what was on the label versus what was inside. Many products labeled as nicotinamide also contained traces of 6-methyl nicotine (a nicotine analog), often undeclared (jamanetwork.com).

In effect, some nixamide-labeled products are blends or contain analog compounds, which muddies the claim of being a pure “nicotine alternative.”

Unknown Toxicology, Speculative Pathways

A recent scoping review on emerging nicotine analogs (6-methyl nicotine and nicotinamide) highlights that safety profiles are largely unknown. The authors speculate possible modes of airway damage via oxidative stress, receptor activation, or inflammatory pathways, but emphasize these are hypotheses, not confirmed effects (researchgate.net).

This uncertainty has sparked comparisons between nicotine’s well-documented neural effects and the unknowns of nixamide. Nicotine’s influence on mood and focus is already well studied, as explored in Does Nicotine Cause Anxiety or Help It?—a resource that helps explain how nicotine interacts with brain chemistry and why many users feel both stimulation and calm. Nixamide, by contrast, hasn’t shown consistent evidence of interacting with those same receptors, leaving its psychological impact unproven.

Other research warns that some e-cigarette chemicals mimic nicotine and may bypass regulation altogether. In some tested devices, ingredient claims didn’t match content, and toxicologists note that “nicotine analogs are currently not subject to the FDA process and have not been studied for their health effects” (eurekalert.org).

Why Researchers and Regulators Are Raising Alarms

When a compound is marketed to deliver nicotine-like effects but escapes regulation, concerns multiply. A coalition of health and tobacco control organizations sent a letter to the FDA urging scrutiny of nicotine analog products, including nixamide, warning that they may be designed to evade oversight (lung.org).

Because analogs are structurally different, some manufacturers claim their products are exempt from tobacco regulation—yet the actual effects, addiction potential, and degradation byproducts remain opaque. For consumers, that means taking an informed approach is essential to staying safe and making conscious choices about what’s being inhaled.

How the Market and R&D Are Responding

Major players in the vaping industry are quietly exploring analogs and hybrid formulations. The push is toward chemicals that mimic nicotine’s binding properties but skirt regulation. That means nixamide is not alone—it’s part of a broader shift.

Still, companies acknowledge that complete inhalation safety testing will take years. Meanwhile, consumers, suppliers, and regulators are watching closely. For those navigating this new space, awareness is the best protection—knowing what’s inside a vape and how it’s represented helps each user make healthier, more informed decisions.

A Thoughtful Approach for Vapers Tracking Nicotine Alternatives

If you’re exploring nixamide or other nicotine alternatives, treat this as an evolving experiment—not a proven path. Here’s how to stay grounded:

• Demand transparency. Prefer products with third-party lab results or certificates of analysis that disclose all contents, including analogs.

• Taper with care. If you aim to reduce nicotine dependence, drop levels gradually rather than switching abruptly to analogs.

• Start low. If testing nixamide products, begin with minimal concentrations and monitor any physical or psychological effects (e.g., jitteriness, mood shifts).

• Track regulation trends. Laws may evolve quickly—what’s legal now might face limits later.

• Keep alternative options in view. For vapers already exploring zero-nicotine, The Truth About Vaping Without Nicotine offers context on what those transitions actually feel like, including the mental and physical adjustments that come with dropping nicotine entirely.

Whether your goal is to quit nicotine or understand what’s new in the market, taking a research-first approach helps protect both your health and your progress. Articles like What Is Nixamide: A Straight-Talk Guide to a New Nicotine Alternative and Does Nicotine Cause Anxiety or Help It? expand this conversation, offering a clearer picture of how these compounds shape behavior, mood, and satisfaction in everyday use.

What “Nixamide Vape Research” Suggests About the Future of Nicotine Alternatives

After months of lab testing and debate, nixamide vape research continues to reveal more questions than answers. What began as a bold idea—to turn a form of vitamin B3 into a satisfying vape ingredient—has opened a new chapter in the conversation about what a nicotine alternative can be.

The early data suggest that nixamide may not behave like nicotine, but it’s still shaping how people think about harm reduction.

Studies confirm that some products labeled as nixamide contain nicotine analogs or inconsistent formulations, reminding researchers and consumers that regulation and transparency still lag behind innovation. Yet, that same uncertainty is what drives exploration forward. Each new study adds to a growing body of evidence that’s redefining what “nicotine-free” might mean in vaping culture.

If future research proves nixamide can create satisfaction without dependence, it could become a landmark step toward a safer nicotine alternative. Until then, the science invites curiosity—and caution. Understanding these findings helps vapers make informed choices as the industry continues to evolve toward options that feel familiar but support healthier habits.

At Ruthless Vapor, we believe knowledge drives better choices. Staying informed, questioning new ingredients, and putting your well-being first are what make harm reduction real—not just possible.

Source link

From exposure to death: how the calculation works

It is a study that has attracted considerable attention. As part of the Global Burden of Disease Study (GBD), a project led by the IHME (Institute for Health Metrics and Evaluation, University of Washington), whose estimates are notably used by the WHO when stating that “a given cause kills a certain number of people worldwide,” second-hand smoke was estimated to have been responsible for 1.66 million deaths worldwide in 2023. The figure has been widely reported by media outlets around the world. Here, we take a closer look at the methodology used to produce it.

Published on September 7, 2026, in the scientific journal The Lancet Public Health¹, the research is the work of more than 1,000 researchers. As is often the case with research on smoking, it was funded by Bloomberg Philanthropies and the Gates Foundation, two organizations also known for funding numerous studies critical of vaping.

Methodologically speaking, there is little point beating around the bush: this research is about as state-of-the-art as it gets for this kind of exercise. Its limitations do not stem from any lack of rigor on the part of the researchers, but simply from the fact that it is impossible to do much better. The aim was to determine the number of deaths caused by second-hand smoke over an entire year and across 204 countries. Since it is not possible simply to count all death certificates recorded around the world, modelling is required, and with it comes an unavoidable degree of uncertainty.

To arrive at their result, the researchers first estimated the number of people exposed to second-hand smoke worldwide: 2.71 billion, including 767 million children. This figure is itself an estimate based on numerous factors.

They then estimated the number of deaths caused by second-hand smoke from the number of people exposed. This was done using a standard epidemiological method that combines two pieces of information: relative risk (RR) and exposure prevalence.

Relative risk is derived from decades of previous research. For each disease associated with second-hand smoke — heart disease, stroke, lung cancer and others — it indicates how much more likely an exposed person is to die from the disease compared with someone who is not exposed.

By combining this relative risk with exposure prevalence (P), a standard statistical formula can be used to calculate the proportion of deaths from a given disease that is attributable to second-hand smoke. This is known as the population attributable fraction (PAF).

This percentage is then applied to the total number of deaths from that disease, which has already been estimated independently by the GBD programme, to obtain the number of attributable deaths. The calculation was repeated for every disease, in each of the 204 countries studied, and by age group and sex, before all the results were added together to produce the final figure: 1.66 million (95% UI 1.33–2.07). In other words, there is a 95% probability that the true number of deaths attributable to second-hand smoke in 2023 lies between 1.33 million and 2.07 million.

The limitations of the method

Of course, this type of study has a number of limitations. The main ones are as follows.

First, the researchers used what could be described as an “all-or-nothing” model. The intensity of second-hand smoke exposure was not taken into account, and each person was classified as either exposed or unexposed. As a result, a child whose parent systematically smokes at the dinner table was classified as exposed in the same way as a child whose parent only smokes by an open window or on a balcony.

Public places were also excluded. The research measured exposure only at home and in the workplace. Bars, restaurants and other public places where smoking is still permitted in some countries were not included.

In addition, the model applied exposure levels from 2023 to mortality rates from that same year. This poses a problem because some diseases associated with second-hand smoke, such as lung cancer, can take several decades to develop after exposure. The study therefore attributed the current disease burden to present-day exposure, even though for several diseases that burden actually reflects exposure in the past.

Finally, almost every new edition of the GBD changes its methodology. It is therefore not possible to directly compare the results of this study with those from previous years. That said, such a comparison would not have been possible anyway, since this is the first time second-hand smoke has been studied as an independent risk factor.

Sources and references

1. GBD 2023 Second-hand Smoke Collaborators. (2026). Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health. https://doi.org/10.1016/S2468-2667(26)00168-4

Source link

Now decades into vaping, one of the most significant topics for all vapers is which nicotine alternatives are preferred to lead to a healthier lifestyle. This is shown through the community, as many vapers are interested in keeping the habits and rituals they enjoy while moving away from nicotine’s addictive pull. That demand has opened the door for new compounds to enter the market, each one promoted as a possible solution.

One of the latest names to surface is nixamide. Advertised as a nicotine alternative, nixamide is built on a compound you might already recognize. The pitch is simple: experience something like nicotine, without actually using nicotine. But how valid is that claim, and what do we really know about it so far?

Before looking at how nixamide is being marketed as an alternative, it’s worth stepping back to understand exactly what it is, where it comes from, and why it’s being added to vape products.

What Is Nixamide?

Over the last few years, vapers have been introduced to a wave of nicotine alternatives, compounds designed to give the satisfaction of nicotine without being regulated as nicotine. Some of these are synthetic analogs that closely resemble nicotine’s structure, while others, like nixamide, come from compounds you might recognize from everyday nutrition.

Nixamide is based on nicotinamide, a form of vitamin B3 that your body naturally uses to support energy production and cell repair. In foods and supplements, nicotinamide has a long record of safe use, which is part of the reason companies have started presenting it as a “cleaner” option in vaping. The marketing pitch is simple: Nixamide may deliver a similar feeling to nicotine without actually being nicotine.

That promise has made it attractive to both manufacturers and vapers. For brands, nixamide opens the door to products they can sell outside of tobacco regulations. For users, it represents the possibility of enjoying the ritual of vaping without the addictive pull of nicotine itself.

But this area is still developing. The science is limited, the claims are often ahead of the evidence, and much of what’s being said comes from marketing rather than peer-reviewed studies. For readers who want a straightforward breakdown of what nixamide is, how it’s being positioned, and what researchers have found so far, our guide What Is Nixamide? A Straight-Talk Guide to a New Nicotine Alternative offers a deeper dive into the topic.

Why Vapers Are Looking at Nixamide as a Nicotine Alternative

For many people, the draw of nixamide is that it seems to fit neatly into the search for a nicotine-free vape. Nicotine’s addictive pull makes quitting or reducing use difficult, so when a product claims to give the same satisfaction without it, it’s tempting.

The reality is more complicated. Nicotine is one of the most studied stimulants in vaping, while nixamide is still relatively untested. Public health experts have warned that positioning it as a direct replacement without data could mislead users (Tobacco partners letter to FDA on nicotine analog products).

If your interest in nixamide is about finding a way out of nicotine dependence, it helps to understand what that process usually looks like. Our guide on How to Stop Vaping on 5% Nicotine shares strategies for tapering, explaining how small, planned steps often make the difference between success and relapse.

The Science Behind Nixamide

One of the reasons nixamide has caught attention is because of how nicotine works. Nicotine binds to nicotinic acetylcholine receptors in the brain, releasing dopamine and producing the “reward” effect that keeps people coming back. If nixamide could do the same thing, it would stand as a powerful alternative.

But so far, research hasn’t shown that nicotinamide interacts with those receptors in the same way. Some animal studies suggest it may have calming or sedative properties, which is the opposite of nicotine’s stimulating effect. Other reviews have shown inconsistencies, with some “nicotinamide-based” vape liquids containing trace nicotine or related compounds (Marketing of nicotinamide as nicotine replacement in electronic cigarettes and smokeless tobacco).

That gap between marketing and science is why many vapers look at nixamide with both curiosity and caution. If you’re weighing it against other options, it helps to compare it to solutions already studied. Choosing the right nicotine strength, for example, can make vaping manageable without the guesswork. Our article on How to Choose the Right Nicotine Strength for Your E-Liquid explains how dialing in strength keeps cravings steady while lowering the urge to overcompensate with untested products.

The Risks of Treating Nixamide as a Nicotine Alternative

The biggest challenge with nixamide isn’t whether it might provide a sensation-it’s the unknowns about long-term safety. Nicotinamide is safe in foods and supplements, but vaping changes the equation. Heating and aerosolizing it may create byproducts that haven’t been studied. Researchers already warn that inhaled vitamins can behave very differently from swallowed ones (Are vape makers using dubious nicotine mimics to bypass regulations?).

That lack of data makes nixamide less reliable as a valid alternative. Without transparency in labeling and without published studies on what happens when it’s inhaled daily, it remains a question mark for vapers who want consistency and safety.

The Future of Nicotine Alternatives

The idea behind nixamide highlights how much demand there is for nicotine-free solutions. As more vapers look for ways to cut back, companies will continue to search for compounds that can be positioned as replacements.

We’re already seeing innovation in areas like lab-made nicotine, herbal blends, and even behavioral approaches that focus on separating the habit from the chemical. In that context, nixamide is part of a bigger story: the industry’s push to create options that sidestep regulation while appealing to users searching for something new.

For those exploring alternatives that already have more established data behind them, What Is Tobacco Free Nicotine? offers insight into how lab-made nicotine is produced and why some vapers choose it over tobacco-derived options. Compared to nixamide’s uncertain profile, tobacco-free nicotine provides a clearer example of how alternatives can be introduced with transparency and consistency.

But for any alternative to earn trust, it needs more than clever marketing. It requires clear studies, lab transparency, and a body of evidence that shows how it works. Until nixamide reaches that point, it’s best understood as a developing idea.

Should You Try Nixamide?

If you’re considering nixamide as a nicotine alternative, keep expectations balanced. It’s marketed as a breakthrough, but without evidence, it remains unproven. Products without lab reports or with vague claims should raise questions.

For vapers who are exploring a nicotine alternative, it’s best to stay informed and compare all the options. Nixamide looks like a developing idea to help wean off of nicotine, where trying tobacco-free nicotine, with lifestyle changes, are all great ideas to start your development towards a healthier lifestyle.

Final Thoughts

The rise of nixamide shows how quickly the search for alternatives to nicotine is evolving. It’s marketed as a compound that could deliver some of the same satisfaction as nicotine, but without being nicotine itself. That promise is appealing to vapers who want options beyond traditional nicotine products.

At the same time, research into nixamide is still limited. While nicotinamide has a long history as a vitamin, its role in vaping is new, and there are still open questions about how it behaves when inhaled. For now, nixamide sits at the intersection of innovation and uncertainty.

For vapers interested in nicotine alternatives, nixamide represents one of the newest possibilities on the horizon. Whether it proves to be effective or not will depend on how science, regulation, and consumer experience shape the story in the years ahead.

Source link

Whether that characterisation is accepted or not, the FDA’s treatment of vaping has undoubtedly been contentious. But the appointment of Bret Koplow, Ph.D., J.D., as permanent director of the Center for Tobacco Products (CTP) could indicate a more pragmatic direction—one that combines strict youth protection with greater recognition of lower-risk alternatives for adults who smoke.

How did the FDA-Vaping conflict come along?

He also criticises the FDA for failing to adequately address widespread misunderstanding of relative risk. That concern has significance beyond the vaping industry because smokers’ decisions depend partly on whether they understand that the primary danger from cigarettes comes from inhaling the products of combustion.

Bret Koplow may be the change the FDA needed

That language reflects the fundamental balance tobacco harm reduction advocates have long requested: differentiate products by risk while preventing youth uptake. More importantly, Koplow’s actions while serving as acting director suggest this may be more than rhetoric. In June, the FDA authorised 20 ZYN nicotine pouch products to carry a modified-risk claim explaining that switching completely from cigarettes to ZYN reduces the risk of several serious smoking-related diseases. Koplow said accurate information about relative harms could help adult smokers make informed decisions.

Is the door to innovation finally being opened?

Perhaps the most significant shift has occurred with vaping itself. In May 2026, the FDA authorised fruit-flavoured e-cigarettes for adult smokers for the first time. Rather than treating flavour and youth protection as necessarily incompatible, Koplow highlighted technology designed to prevent underage access as potentially transformative. The decision suggests a regulatory model in which innovation could address competing objectives: preserving products that may appeal to adult smokers while using technological safeguards to restrict youth access.

The emerging philosophy therefore looks less like deregulation and more like risk-proportionate regulation: facilitate scientifically supported alternatives for adult smokers while acting aggressively against products and marketing practices that threaten youth.

Moving from senseless war to sensible regulations

The FDA regulates a market in which cigarettes—the most dangerous widely used nicotine product—coexist with non-combustible alternatives capable of delivering nicotine without burning tobacco. A coherent regulatory system should recognise those differences while ensuring that products intended for adult smokers do not create unnecessary risks for children.

Clickbait Obsession: Makary’s FDA Exit Revealed Media’s Preference for Political Theater Over Science

Source link

If you spend time in the vape community, you’ve likely seen a new question come up: What is Nixamide? The name has started to appear in product listings, social posts, and even research. It’s promoted as a nicotine alternative, giving people the idea that there may be a way to enjoy the familiar routine of vaping without nicotine itself.

The idea is compelling. Vapers are always curious about options that might offer control, variety, or even a different type of satisfaction. But whenever something new arrives, the vital step is to slow down, separate fact from marketing, and take the time to understand the nuances behind the trending topics.

What Is Nixamide?

Nixamide is a proprietary blend that centers on nicotinamide (vitamin B3). It’s suspended in the same base liquids commonly used in e-liquids-vegetable glycerin (VG) and propylene glycol (PG). Unlike synthetic nicotine or tobacco-derived products, Nixamide contains no nicotine molecules at all, whether in their natural (S-(-)) form, mirror image (R-(+)) form, or a racemic mix. Analytical testing has confirmed that nicotine is absent at the detection threshold, a point echoed in peer-reviewed analysis.

From a regulatory perspective, this distinction matters. Current correspondence indicates that Nixamide may not be classified as a “tobacco product” under the Food, Drug, and Cosmetic Act. Public health groups have noted this gap in oversight in a letter to the FDA, highlighting how nicotine alternatives sit outside existing rules.

Consumer experiences add another layer. Some describe Nixamide as producing a “buzz,” while others call it “a nice warm hug” or a tool that helped them ease away from nicotine. While it all depends on how individuals interpret the effects, researchers stress that, like all nicotine alternatives, more studies should be conducted to compare Nixamide to other established compounds. Early work, such as findings from Duke Health, suggests that some nicotine-like chemicals can mimic the real thing, which makes ongoing research essential.

In short, when people ask What is Nixamide?, the answer is that it’s a nicotine alternative made with nicotinamide and common vape carriers, promoted as nicotine-free, and currently sitting outside tobacco regulation.

Why a Nicotine Alternative Like Nixamide Is Getting Attention

The rise of Nixamide is connected to the search for new options. Many vapers are looking for alternatives that feel satisfying while offering a way out of traditional nicotine use. At the same time, manufacturers see an opening in how products are classified.

Researchers at Duke Health have reported that certain e-liquid chemicals are engineered to mimic nicotine’s effects but may not fall under current definitions of tobacco products. That regulatory gray area has drawn interest because it allows companies to bring products to market more quickly.

Public health organizations have noticed the same trend. In a formal letter to the FDA, several groups urged regulators to examine nicotine analog products, including those labeled as Nixamide. Their concern is less about shutting down innovation and more about ensuring accuracy and oversight.

This is why searches for What is Nixamide? have increased. It isn’t just a chemical story-it’s also part of a bigger discussion about regulation, labeling, and consumer trust.

How Vapers Interpret a Nicotine Alternative

From the perspective of the vaping community, a nicotine alternative like Nixamide represents a possibility. It suggests there might be a way to continue the ritual without the same associations tied to nicotine. For some, that sounds like a step toward freedom. For others, it sparks curiosity about flavor, sensation, and variety.

At the same time, there are practical considerations. If a bottle labeled as a nicotine alternative contains undisclosed analogs, then its effects may not match expectations. That doesn’t make it inherently unsafe, but it does create uncertainty. Until more studies are done, Nixamide is best understood as a work in progress rather than a proven replacement.

Options Already Available for Control

If your curiosity about “What is Nixamide?” comes from wanting more control, there are already tools you can use with clarity and consistency. One of the most straightforward steps is adjusting your vape nicotine level. Tapering gradually lets you reduce intake without giving up the habit entirely.

For people interested in trying the routine without nicotine at all, nicotine-free vape juice provides a straightforward option. You know what’s in the bottle, and you can see how your experience feels when nicotine isn’t part of it.

Another perspective comes from how companies describe tobacco-free nicotine. While these products are still nicotine at the molecular level, they show how the industry is experimenting with alternatives and language. Comparing those examples with Nixamide helps put the idea of a nicotine alternative into context.

The Current Risks and Unknowns

Any new product comes with questions. For Nixamide, the main issues are consistency, labeling, and long-term study. The JAMA research showed that some nicotine analog liquids don’t always contain what they claim. Duke Health’s findings that certain compounds may be misleading, which can raise questions about oversight. The American Lung Association’s letter reflects some concern that regulations may not have caught up yet.

These points don’t make Nixamide unsafe by default-they highlight that it’s early. When people ask What is Nixamide?, the answer is that it’s an emerging product type with potential, but not yet a fully defined category.

Looking Ahead: Where Does a Nicotine Alternative Fit?

The vaping industry is constantly evolving. Flavors shift, devices change, and new compounds are introduced. Nixamide is one example of how fast innovation moves when consumers are curious and manufacturers see opportunity.

Whether Nixamide becomes a lasting part of the market will depend on research, regulation, and consumer experience. If studies show consistent effects and safety, then it may establish itself as a valid nicotine alternative. If not, it may fade as one of many experiments along the way.

Conclusion: A Balanced Take on Nixamide

Nixamide has entered the spotlight because it promises something vapers have long wondered about-a genuine nicotine alternative that delivers familiar sensations without nicotine itself. It’s built around nicotinamide, tested to be free of nicotine, and currently sits outside tobacco regulation. Some consumers report positive experiences, while researchers highlight the need for more study and oversight.

As of now, the question “What is Nixamide?” doesn’t have a final answer. It represents innovation and possibility, but also uncertainty. We encourage vapers to stay curious but to do their due dilligence and to utilize the tools that are already available. Tapering nicotine levels and exploring nicotine-free juice are all options to consider for a safe and precise approach to your smoking journey- whether quitting or wanting to taper your nicotine ingestion.

Source link

Just weeks after Britain’s new vaping tax takes effect, another major set of nicotine regulations will take effect, adding to what is becoming one of the biggest transformations of the UK’s vaping market in years.

The Government itself has recognised the importance of maintaining a price advantage for vaping over smoking. When designing the duty, it explicitly provided for an accompanying tobacco-duty increase to preserve the financial incentive for smokers to choose vaping rather than cigarettes.

Another layer of regulations is added on October 29th

Adults will also be prohibited from buying—or attempting to buy—these products on behalf of someone under 18. Proxy purchasing can result in a £200 fixed penalty in England, Wales and Scotland and £250 in Northern Ireland, while retailers caught selling directly to minors can face larger penalties if prosecuted.

The new restrictions cannot be considered in isolation

The more difficult question concerns the cumulative effect of Britain’s new vaping policies. The previously discussed October tax does not arrive in isolation. The Government is also considering restrictions affecting vape displays, flavour descriptions, packaging and device appearance. Together, these policies could change not only how much vaping costs, but how easily smokers notice, understand and choose products as alternatives to cigarettes.

ELFBAR extrapolated that response across Britain’s vaping population and estimated that as many as 550,000 adults could potentially increase or resume smoking. Using estimates of smoking’s wider economic burden, the company calculated a theoretical maximum cost of approximately £4.5 billion annually.

That figure should not be interpreted as a prediction. It assumes stated intentions translate into behaviour and that all those affected are former smokers who subsequently resume smoking. Nevertheless, it highlights an unintended consequence policymakers need to consider.

Are lawmakers forgetting what actually matters?

Against that background, the key question surrounding restrictions should not be whether they reduce vaping, but whether they reduce smoking.  Preventing underage sales, proxy purchasing and irresponsible promotion can be pursued without undermining adult access. The 29 October measures largely illustrate that approach.

Timing matters here. From October 1st, vaping becomes more expensive through the VPD. Four weeks later, wider age and promotional controls arrive, while further restrictions on product presentation remain under consideration. Each measure may have a different objective, but smokers experience their cumulative effect.

The test for Britain’s evolving nicotine strategy should therefore be broader than whether fewer people vape. Youth uptake should fall, illegal sellers should face meaningful enforcement and regulated businesses should comply with strict age controls. But adult smoking should fall too – and this should be the priority

If Britain can strengthen youth protections while keeping regulated smoke-free products sufficiently affordable and accessible to compete with cigarettes, the two objectives can reinforce one another. If cumulative restrictions instead discourage switching, encourage relapse or drive consumers towards illicit markets, reducing vaping could come at the expense of reducing the behaviour responsible for vastly greater harm: smoking.

The UK’s Disposable Vape Ban One Year Later: Rising Smoking Rates and Illicit Markets, as Predicted

Source link

While a back-and-forth take on nicotine, some may state that nicotine sharpens focus or clears the mind. On the other hand, some may disagree. But the connection between nicotine and memory/attention is, like all things nicotine, a field that’s been studied for decades. While some research shows short bursts of alertness, the longer picture of nicotine dependence may prove a different idea.

Vaping culture, in general, may promote the usage of nicotine as it may be linked to show short bursts of alertness. However, the reality is that the relationship between nicotine and attention may be a layered concept. With longer-term health issues that may arise, there is an evident link between nicotine and memory/attention, whether it be good or bad.  

How Nicotine Affects Attention in the Short Term

Nicotine interacts with receptors in the brain that release neurotransmitters like dopamine and acetylcholine, which are shown to be tied to alertness, learning, and focus. Research shows that nicotine can briefly speed up reaction times and improve performance on tasks that demand sustained attention. For some, this explains why vaping before studying or driving feels like it “turns the lights on” upstairs.

But the catch is that this boost doesn’t last. Once nicotine levels drop, attention tends to fade and may leave people feeling mentally scattered. Over time, this cycle can create dependence, as the brain learns to expect nicotine to maintain focus. We explore this idea further on how nicotine affects dopamine.  

Nicotine and Memory: Gains and Tradeoffs

On the other hand, some experiments suggest nicotine might improve working memory in controlled settings, with working memory being the ability to hold information temporarily. However, long-term usage shows a different side, as chronic nicotine exposure can actually reduce overall memory performance.

Studies show that heavy ingestion of nicotine poses a greater risk of memory lapses and/or cognitive decline later in life, meaning that some may feel sharper in the moment but may see memory decrease in the longer term.

We’ve written about the effects of nicotine on the brain, where similar themes emerge: what feels like relief in the short run may feed into the very struggles, like stress or forgetfulness, that users want to escape.

Short-Term vs. Long-Term Cognitive Effects

Looking at nicotine and memory/attention means understanding two very different timelines. In the short term, studies show nicotine can help with repetitive tasks, sharpen reaction speed, and make it easier to stay engaged on boring assignments. That’s why many people say they feel more productive with a vape in hand. But over the long term, studies link chronic nicotine exposure with impaired memory performance.

Studies show that it’s a double-edged sword, as the usage of nicotine may make you sharp immediately, but it may show long-term decline in the future. The contrast highlights how the vaping culture is correct- with immediate effects, but may run into cognitive decline in the future, if not already showing signs of it.

Habits, Cues, and the Attention Loop

Nicotine goes beyond the chemistry behind it all and exhibits signs in the behavior. Many vapers- and people in general- build their rituals around focusing: ingesting nicotine before studying, on their work breaks, or during gaming time. Over time, these moments become cues, where the brain starts to expect nicotine anytime attention drifts.

This is what behavioral scientists call conditioning, and it’s a big reason why nicotine feels tied to concentration. The habit becomes as powerful as the substance. As explained in our article on nicotine dependence, the loop reinforces itself: distraction triggers a craving, the vape delivers a reset, and soon the cycle feels impossible to break.

Withdrawal and Cognitive Fog

One of the most evident signs of dependence is what happens when nicotine is removed. Many people experience brain fog, slower recall, and difficulty concentrating during withdrawal. Studies confirm that nicotine withdrawal is tied to deficits in sustained attention, working memory, and response inhibition.

These deficits aren’t just anecdotal, as in deprived smokers, nicotine replacement improves task performance related to attention and working memory. The fog is temporary, yet it convinces many that they need nicotine to function. According to many, the first days bring headaches, irritability, and poor focus, but weeks later, cognitive clarity often improves.

Other Paths to Better Focus and Memory

In the short term, nicotine can bring a sense of relief, as the brain has been conditioned to depend on it routinely. However, other factors have been shown to have a considerable influence on brain performance. Sleep is one of the strongest predictors of attention and memory. Missing even a few hours can impair focus more than nicotine ever restores. Exercise is another powerful tool, as studies show that physical activity increases blood flow to the brain and strengthens memory networks. Diet also matters, as foods rich in omega-3 fatty acids and antioxidants support long-term brain health.

For many, vaping fills the role of a quick mental boost, but the tradeoff is that it keeps attention dependent on a cycle of peaks and valleys. Choosing routines that naturally improve focus builds steadier performance without the crash. Readers who want to see how lifestyle plays into nicotine recovery can revisit our effects of vaping guide, where sleep, diet, and stress management all connect to healthier brain function.

Why Vapers Keep Linking Nicotine and Concentration

Cultural habits reinforce the idea that nicotine equals focus. Coffee breaks with cigarettes, study sessions with a vape pen, or late-night work paired with a hit; these nicotine habits are all built into routines. These habits make it easy to assume nicotine, which directly fuels concentration, even when science shows the effect is temporary.

The reality is that many of these rituals revolve around the moment of pause itself. There are other options to consider if you’re trying to cut back on nicotine: taking a step away from work and breathing deeply during an inhale may give the brain the reset it needs. While being a simple alternative, it really depends on the user and exploring different options for a brain reset- that don’t involve nicotine. The environment plays a significant role in changing how habits are formed, which, in terms, can break the cycle of dependence.

Tying Back to the Bigger Picture

Our broader exploration of the effects of vaping brings all these threads together. Memory, attention, stress relief, and dependence are all connected by how nicotine interacts with the brain. Understanding this bigger picture helps explain why vapers experience both benefits and setbacks.

The goal isn’t just to focus on what happens in the next five minutes of concentration, but to consider what years of nicotine exposure could mean for memory health. By grounding decisions in research and personal experience, readers can weigh the real tradeoffs behind the daily hit.

Final Thoughts

Studies show that there is a relationship between nicotine and memory/attention. While the short-term effects can make focus feel sharper, the long-term impact often works against memory health and concentration. Much of the “boost” comes from relieving withdrawal, creating a cycle that vapers know well: sharpness followed by cravings, clarity followed by fog. Pitted in everyday habits, the environment of individuals plays a significant role in nicotine dependence. Studies show that, while more complicated than it may seem, other alternatives to nicotine can help users quit, where it’s essential to recognize the habits that have been built into the nicotine dependence itself. Some healthier routines, like sleep, exercise, and balanced nutrition, can help users if they aim to wean off nicotine.

At Ruthless Vapor, we explore these connections to help our community make educated decisions on what they ingest every day. Understanding how nicotine interacts with the brain gives every reader the chance to see the whole picture and make informed choices on a healthier lifestyle.

Source link

An all-terrain kit

The Armour Octa kit is ready to accompany vapers in many different situations, including the most adventurous ones. Particularly well protected against water, dust and everyday knocks, the kit runs on two 18650 batteries. An all-round setup designed for direct lung vaping in any situation.

Technical specs

The box includes:

• Mod
• Clearomizer
• Spare tank
• Spare parts
• USB cable
• Coils
• User manual

A rugged and fully featured mod

The top of the mod accommodates the iTank T clearomizer supplied with the kit. It can also take your favorite atomizer up to 24 mm in diameter at the base without any overhang. The connection is spring-loaded for reliable contact. A slightly raised section around the connection helps protect the mod from scratches when fitting or removing the clearomizer.

On the front, there is a contrasting fire button, a color screen, two buttons for navigating the menus and adjusting settings, and a USB-C port protected by a flexible silicone cover. It is a familiar layout for a box mod, but the ergonomics have clearly been designed for comfortable everyday use.

The mod runs on two 18650 batteries. The battery door is solid, and a small latch makes it easier to open. Battery polarity is clearly indicated, making incorrect installation virtually impossible. Once the batteries are fitted, there is no noticeable movement inside the compartment and no pressure on the door. The overall fit and finish are excellent.

On the side of the mod, a sliding switch locks the device. A padlock symbol indicates whether the mod is locked or unlocked. This feature is particularly useful during transport, helping to prevent accidental firing without having to switch the device off using the more traditional sequence of repeated button presses. Most of the body is covered with a shock-absorbing coating that also has a pleasant texture and improves grip.

The mod’s screen is simple and displays all the essential information, including selected wattage, puff count and coil resistance.

The mod delivers between 5 and 220 W. The menus are conventional and uncomplicated, while still covering the majority of vapers’ needs.

The available vaping modes are Pulse, Eco, Boost and TC for temperature control.

In Pulse mode, the mod makes brief power variations while vaping. The result is a more sustained sensation, with greater presence in the mouth and increased vapor production.

Eco mode focuses on more conservative battery use. Power is delivered in the conventional way, without the variations used in Pulse mode. This helps reduce strain on the batteries and extend battery life during everyday use.

Boost mode is designed to bring the coil up to its ideal operating temperature quickly. More power is applied at the start of each puff in order to immediately produce a generous amount of vapor. It is the mode to choose when you want a rapid ramp-up and dense vapor from the very beginning of the draw.

Temperature control is also included, even though only a very small minority of vapers are likely to use it. The Smart function is still present and automatically suggests a suitable wattage range according to the resistance of the coil fitted in the clearomizer.

Naturally, the screen backgrounds can also be changed.

A clearomizer built for clouds

The clearomizer supplied with the kit is the iTank T. It has a 6 ml capacity, which is ideal for direct lung vaping. It uses a top-airflow design, meaning the air inlets are positioned at the top of the clearomizer. This system is reliable and helps prevent potential leaks. The clearomizer measures 23 mm in diameter at the base, although the beveled shape of this section quickly widens to 24.5 mm.

Filling is easy. Simply slide the top section to access the fill port, which is protected by a split seal. The opening point is marked with a small red arrow, so there is no room for confusion.

Airflow adjustment is made easier by numbered markings on the rotating ring. The more the airflow is opened, the airier the draw becomes. Conversely, the iTank T becomes more restricted when the amount of incoming air is reduced. In every configuration, however, this clearomizer is intended exclusively for direct lung vaping.

Installing the coil requires no particular skill. Simply unscrew the base of the clearomizer and insert the coil, which is held in place by seals as well as the screw-on base.

Two coils are supplied with the kit: GTI coils rated at 0.2 and 0.4 ohm. The 0.4-ohm GTI is a dual-mesh coil designed for use between 50 and 60 W. The 0.2-ohm GTI is also dual mesh, but is intended for vaping between 60 and 75 W.

In terms of vaping performance, the results are excellent. Vaporesso has been using GTI coils for a long time, and they consistently provide excellent flavor reproduction. Whether vaping fruity, dessert-style or menthol e-liquids, there are no issues to report. The result is powerful, dense and precise, with substantial vapor production that is fully in line with the selected wattage.

In summary

What we like

• Fit and finish
• Durability of the mod
• Simple menus
• Clearomizer capacity
• Flavor quality

What we don’t like

Source link

Vaping often raises a question that doesn’t have an easy answer: Does nicotine cause anxiety or help it? For many, the first vape of the day feels like a release. The stress seems to lift, and the moment feels calmer. Yet for others, the same nicotine hit sparks racing thoughts, restlessness, or tension. This back-and-forth experience has been documented for decades in both smoking and vaping research, and the science shows that nicotine can act like a double-edged sword.

Understanding whether nicotine helps or worsens anxiety matters for anyone who vapes daily. The answer connects to how nicotine works in the brain, how it interacts with stress systems, and how dependence builds over time.

How Nicotine Affects the Brain and Stress

Nicotine is a stimulant that interacts with receptors in the brain tied to dopamine and adrenaline. When inhaled, it enters the bloodstream quickly and creates a fast surge of neurotransmitters. For some, that release creates a calm or focused state. The body perceives relief not because nicotine itself removes anxiety, but because it eases the tension caused by withdrawal.

This cycle explains why vaping can feel calming after long gaps between use. Anxiety builds as nicotine levels drop, and the next inhale provides what feels like relief. The calmness is temporary, and as the effect fades, the brain begins craving again. Over time, this rollercoaster can make stress and anxiety feel stronger rather than weaker.

The science goes deeper at the receptor level. Nicotine binds to nicotinic acetylcholine receptors in the brain, which then trigger the release of dopamine. That dopamine spike feels rewarding and explains why the next hit feels so tempting. At the same time, nicotine stimulates cortisol, a stress hormone. The dopamine effect is short-lived, often lasting only minutes, while cortisol lingers much longer. This is why someone can feel calm for a moment but restless again soon after.

With repeated use, tolerance begins to build. The brain reduces sensitivity to these receptors, which means the same nicotine level produces less relief. That balance pushes people into using more frequently to chase the calm, while the background level of stress hormones stays high.

Our article on nicotine and dopamine expands on how the brain’s reward system drives the need for “just one more hit,” which often plays into the anxiety cycle.

Does Nicotine Cause Anxiety or Help It? The Paradox

The paradox of nicotine is that it can feel like it reduces stress while contributing to it at the same time. Short-term, it might make you feel less anxious. Long-term, it often amplifies the very feelings people want to avoid.

Research on smoking shows that people with anxiety disorders have higher rates of nicotine dependence. While nicotine can create a sense of calm for a moment, studies point out that the relief comes from correcting withdrawal symptoms, not from easing true anxiety. This pattern means nicotine is both the cause and the temporary fix.

For vapers, this raises an important point. If anxiety seems tied to whether or not you’ve had a hit, the substance itself is shaping the cycle. That doesn’t mean the feelings aren’t real; it means the root of the stress might be linked to nicotine rather than life outside of vaping.

Anxiety, Dependence, and Withdrawal

Nicotine withdrawal is a significant reason anxiety spikes. When someone goes hours without vaping, restlessness and irritability often set in. These are classic withdrawal symptoms, and many mistake them for natural anxiety. The brain begins to associate relief with vaping, making the pattern even stronger.

Over time, this cycle builds dependence. Research on withdrawal symptoms, covered in our breakdown of How to Stop Vaping 5% Nicotine, shows that anxiety often peaks within the first few days of quitting. That spike isn’t proof that nicotine reduces anxiety: it shows how much the body has adapted to needing it.

The withdrawal process has a predictable timeline. Within hours of the last hit, many experience irritability and difficulty focusing. By day two or three, anxiety and cravings often peak. These symptoms usually start to taper off within a week, but in some cases can last longer depending on the level of dependence. Understanding this timeline helps separate everyday stress from the unique pressure caused by withdrawal.

It’s also helpful to distinguish between natural anxiety and nicotine-driven anxiety. If feelings of restlessness appear only when vaping has been skipped, that’s a strong indicator of withdrawal. If anxiety persists regardless of nicotine levels, it may point to an underlying condition separate from vaping. For many, recognizing this difference brings clarity and helps reshape how they view the cycle.

Triggers also play a significant role. Coffee breaks, driving, or even sitting down with friends can become cues that spark both cravings and anxious feelings. The brain wires these everyday moments to expect nicotine, and when the hit doesn’t arrive, stress builds quickly. That pairing of habits and chemicals creates a loop that feels difficult to break.

Tying It Back to The Effects of Vaping

This topic fits into the broader question many ask: What are some common risks for vaping? Anxiety is only one part of the picture. Nicotine dependence affects mood, focus, and sleep, while vaping habits themselves can change how people experience daily life. Looking at anxiety in isolation misses how interconnected vaping is with other physical and psychological effects.

Sleep disruption is a strong example. Nicotine stimulates the nervous system and can interfere with deep sleep. Poor sleep, in turn, increases the likelihood of anxious thoughts during the day. This cycle shows how nicotine’s reach goes beyond the moment of vaping: it shapes daily rhythms that make stress more complicated to manage.

The way nicotine is perceived also adds to the confusion. While many vapers view vaping as a relaxant, science indicates that nicotine is a stimulant. That disconnect explains why the lived experience of relief doesn’t match the long-term evidence of increased stress. By connecting these dots, the bigger picture of vaping’s effects comes into view.

Studies also show that smoking cessation or tapering nicotine often leads to reduced anxiety and improved long-term mood. While the early withdrawal phase can be uncomfortable, the body eventually resets to a more stable baseline. This outcome is an important reminder: what feels like help in the short term may be contributing to the very stress people want to escape.

What This Means for Daily Vapers

For someone who vapes regularly, nicotine may feel like a solution for stress. The science shows it’s more of a short-term patch that can intensify anxiety in the long run. That doesn’t mean the relief you feel isn’t real. It means the cause and effect are more complex than they appear at first.

Understanding how nicotine works can give you clarity on the question: Does nicotine cause anxiety or help with it? The relief may be short-term and temporary, but it may not be suitable for long-term anxiety management. While a quick hit can calm the nerves, nicotine dependence can often lead to stronger anxious feelings, which may inadvertently affect your overall mood.

For anyone who is considering handling their nicotine dependence, exploring how nicotine affects anxiety is a vital point to consider. Paired with healthy routines and awareness of withdrawal, nicotine education helps bring balance back into focus.

Source link

The extent of the problem with illegal tobacco is already considerable. From April 2025 to March 2026, HMRC and the Border Force reported seizing about 1.9 billion illicit cigarettes, with an estimated revenue value of around £1.1 billion. Moreover, the Government’s own strategy on illicit tobacco admits that cheap illegal cigarettes give smokers access to an unregulated supply that can weaken the deterrent effect of high tobacco prices.

Industry research recently brought to light by Convenience Store has also raised concerns among independent retailers, since JTI’s Pack Swap data indicates that a high percentage of the cigarettes and hand-rolling tobacco inspected were not subject to UK duty payment. Although these estimates are based on industry sources rather than official market data, they support what the government’s enforcement statistics have already shown: illegal tobacco remains deeply embedded in certain areas of the retail sector.

Illicit tobacco: much more than a revenue issue

This raises an important question regarding tobacco harm reduction: if there is continued demand for nicotine, then what legal alternatives are smokers being advised to select? For many years, Britain adopted a fairly practical attitude towards vaping –  one that had proved successful. The government still holds the view that vaping is less harmful than smoking and that it can assist adult smokers to quit. Strong evidence supports this. The most recent Cochrane living review, which included evidence up to January 2026, once again concluded that nicotine vapes are more effective at helping people to stop smoking than conventional nicotine replacement therapy. Despite this, sadly, the economics of this kind of substitution are now changing.

New vape tax pressures the wrong recipients

Director General of UKVIA, John Dunne, says that viewing compliant vape retailers as businesses which contribute little to their local communities is difficult to square with Britain’s own acknowledgement of vaping as a means of quitting smoking. The association is not asking for less stringent action against illegal sellers; rather, it is urging policymakers to distinguish between responsible specialist retailers and companies that sell illicit products or supply them to minors.

A licensing scheme would be the way to go

That distinction is likely to matter more when duty stamps are introduced alongside the new vaping tax. Starting in October, compliant products entering the market will need stamps, and from April 2027 almost all vaping products not in duty-suspension arrangements will need one. The Government says the scheme should make it easier to identify legal products and help enforcement against illicit trade.

Safer options should remain affordable and accessible

From the point of view of tobacco harm reduction, the reasonable course of action is not to relax cigarette regulations, but to make sure that legal, lower-risk alternatives are easier and more appealing to get than combustible tobacco from the black market.

If genuine vape shops face excise duties, higher operating costs, and stricter regulation, while illegal cigarette sellers escape all three, the imbalance will, of course, become counterproductive.

Source link